In Segment A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants might be enrolled in the recognized monotherapy dosign regimen. In Segment B, individuals will get oral ruxolitinib and ABBV-744 will be provided as "increase-on" therapy. In Phase C, contributors https://abbv-744-cancer-treatment01346.tkzblog.com/31896590/how-much-you-need-to-expect-you-ll-pay-for-a-good-abbv-744-combination-therapy-with-chemotherapy